Patients with severe (serum sodium ≤120 mEq/L), symptomatic hyponatremia can develop life-threatening or fatal complications from cerebral edema if treatment is inadequate and permanent neurologic disability from osmotic demyelination if treatment is excessive. Unfortunately, as is true of all electrolyte disturbances, there are no randomized trials to guide the treatment of this challenging disorder. Rather, therapeutic decisions rest on physiologic principles, animal models, observational studies, and single-patient reports. European guidelines and recommendations of an American Expert panel have come to similar conclusions on how much correction of hyponatremia is enough and how much is too much, but there are important differences. We review the evidence supporting these recommendations, identifying areas that rest on relatively solid ground and highlighting areas in greatest need of additional data.
28 June 2023 in Clinical Journal of the American Society of Nephrology
International guidelines designed to minimize the risk of complications that can occur when correcting severe hyponatremia have been widely accepted for a decade. On the basis of the results of a recent large retrospective study of patients hospitalized with hyponatremia, it has been suggested that hyponatremia guidelines have gone too far in limiting the rate of rise of the serum sodium concentration; the need for therapeutic caution and frequent monitoring of the serum sodium concentration has been questioned. These assertions are reminiscent of a controversy that began many years ago. After reviewing the history of that controversy, the evidence supporting the guidelines, and the validity of data challenging them, we conclude that current safeguards should not be abandoned. To do so would be akin to discarding your umbrella because you remained dry in a rainstorm. The authors of this review, who represent 20 medical centers in nine countries, have all contributed significantly to the literature on the subject. We urge clinicians to continue to treat severe hyponatremia cautiously and to wait for better evidence before adopting less stringent therapeutic limits.
4 April 2019 in Clinical Journal of the American Society of Nephrology
In this issue of the Clinical Journal of the American Society of Nephrology, Chauhan et al. (3) challenge the idea that rapid correction (defined as >0.5 mEq/L per hour or >12 mEq/L in 24 hours) causes neurologic injury in hypernatremic adults. Using the Medical Information Mart for Intensive Care-III, the investigators identified 122 patients who were admitted to the hospital with serum sodium concentrations >155 mEq/L and 327 patients whose serum sodium rose to >155 mEq/L while in the hospital. Of the patients with hospital-acquired hypernatremia, 128 were considered “chronic,” because the disturbance developed over >48 hours. The hourly rate of correction was computed from the time required to lower the serum sodium from its peak to a level of 0.5 mEq/L per hour in 32 of the patients who were hypernatremic on admission (likely due to a chronic disturbance) and 122 patients with hospital-acquired hypernatremia (both acute and chronic). Mortality rates were no different in patients who were rapidly corrected and patients who were slowly corrected. A review of ICD9 (International Classification of Diseases, Ninth Revision) codes, imaging reports, and discharge summaries failed to identify any patient who developed seizures or cerebral edema during correction of hypernatremia. Similarly, a manual review of daily progress notes available for 46 of the patients who were chronically hypernatremic found no evidence of neurologic morbidity related to rapid correction.
8 September 2021 in American Journal of Kidney Diseases